Population-Based Risk of Mycobacterial Infections Associated With Anti-Tumor Necrosis Factor (anti-TNF) Therapy in Older Patients in Ontario, Canada
Sarah K. Brode(University Health Network), Theodore K. Marras(University of Toronto), Jeff Kwong(University of Toronto), Alex Marchand‐Austin(Public Health Ontario), J. Michael Paterson(University of Toronto), Michael A. Campitelli(Mount Sinai Hospital), Claire Bombardier(Toronto General Hospital), Ryan Ng(Institute for Clinical Evaluative Sciences), Ping Li(Sun Yat-sen University), Frances Jamieson(University of Toronto)
Cited by 1
Related Papers
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
|Arthritis & Rheumatism|1990|9.6k
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
|New England Journal of Medicine|2000|4k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
|New England Journal of Medicine|2018|1.2k